Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M. M. F. Fickers"'
Autor:
M. M. F. Fickers, Hendri H. Pas, J. A. M. J. v.d. Kley, D. C. Flikweert, J. A. Duijvestijn, P. H. M. H. Theunissen, W. N. K. A. van Mook
Publikováno v:
Annals of Oncology. 12:115-118
Summary The case history of a 61-year-old male patient is described, who presented with severe stomatitis, conjunctivitis and leukocytosis The diagnosis chronic lymphocytic leukemia (CLL) stage A (0) was made, for which no treatment was necessary Pro
Publikováno v:
The Netherlands Journal of Medicine. 55:235-241
A 49-year-old patient with refractory acute myelogenous leukemia (AML) is described who developed fever and herpes-like skin lesions during treatment with G-CSF. Skin biopsies revealed dermal neutrophilic infiltrates compatible with the diagnosis of
Autor:
C. T. B. M. Van Deursen, P. J. Brombacher, M.P. van Dieijen-Visser, J.W.J. van Wersch, J. van Pelt, M. M. F. Fickers, J. L. L. M. Coenen
Publikováno v:
Clinical Chemistry. 37:560-563
We determined serum ferritin, C-reactive protein (CRP), fibrinogen, and the erythrocyte sedimentation rate (ESR) in 73 patients with anemia of chronic disease. Nomograms of CRP, ESR, or fibrinogen vs ferritin concentrations were constructed and used
Autor:
M. M. F. Fickers, Frans L. G. Erdkamp, Jaap Wals, F. P. J. Peters, Harry C. Schouten, J.A. Wils
Publikováno v:
Annals of hematology. 80(7)
A substantial part of elderly patients (with good performance) with intermediate or high-grade non-Hodgkin's lymphoma (NHL) are not treated with the standard chemotherapy of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). If NHL pa
Publikováno v:
Annals of hematology. 80(4)
Little is known about the effects of primary splenic irradiation (SI) in B-cell chronic lymphocytic leukemia (B-CLL) on subpopulations of lymphocytes, immunoglobulins, and the induction of autoantibodies against erythrocytes and platelets. Twenty-fou
Publikováno v:
Annals of Hematology. 70:279-280
A patient with idiopathic myelofibrosis is reported who developed a drug fever after treatment with hydroxyurea, a generally effective and well-tolerated drug in chronic myeloproliferative syndromes. Typically, this form of fever develops after a few
Autor:
H. Bron, F. P. J. Peters, Harry C. Schouten, F.L.G. Erdkamp, M. M. F. Fickers, Roy I. Lalisang
Publikováno v:
The Netherlands Journal of Medicine. 50:A5